BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28501127)

  • 61. Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
    Belia F; Kim KY; Agnes A; Park SH; Cho M; Kim YM; Kim HI; Persiani R; D'Ugo D; Biondi A; Hyung WJ
    Eur J Surg Oncol; 2024 Jun; 50(6):108359. PubMed ID: 38657377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mesogastrium: a fifth route of metastasis in gastric cancer?
    Xie D; Osaiweran H; Liu L; Wang X; Yu C; Tong Y; Hu J; Gong J
    Med Hypotheses; 2013 Apr; 80(4):498-500. PubMed ID: 23403142
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.
    Kanda M; Mizuno A; Fujii T; Shimoyama Y; Yamada S; Tanaka C; Kobayashi D; Koike M; Iwata N; Niwa Y; Hayashi M; Takami H; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Jun; 23(6):1934-40. PubMed ID: 26847679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers.
    Hoskovec D; Varga J; Konečná E; Antos F
    Acta Cir Bras; 2012 Jun; 27(6):410-6. PubMed ID: 22666759
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
    Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
    Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peritoneal washing cytology in gastric cancer. How, when and who will get a benefit? A review.
    La Torre M; Rossi Del Monte S; Ferri M; Cosenza G; Mercantini P; Ziparo V
    Minerva Gastroenterol Dietol; 2011 Mar; 57(1):43-51. PubMed ID: 21372769
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
    Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
    Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.
    Nakayama Y; Gotohda N; Shibasaki H; Nomura S; Kinoshita T; Hayashi R
    Surg Today; 2014 Nov; 44(11):2146-52. PubMed ID: 24831660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Prognostic value of peritoneal lavage cytology in gastric cancer].
    de Manzoni G; Di Leo A; Tomezzoli A; Pedrazzani C; Piubello Q; Bonfiglio M; Valloncini E; Veraldi GF
    Chir Ital; 2002; 54(1):1-6. PubMed ID: 11941998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
    Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
    Lee IS; Lee H; Hur H; Kanda M; Yook JH; Kim BS; Woo Y; Kodera Y; Kim K; Goel A
    Clin Cancer Res; 2021 Apr; 27(8):2292-2300. PubMed ID: 33558424
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recurrence following laparoscopy-assisted gastrectomy for gastric cancer: a multicenter retrospective analysis of 1,417 patients.
    Song J; Lee HJ; Cho GS; Han SU; Kim MC; Ryu SW; Kim W; Song KY; Kim HH; Hyung WJ;
    Ann Surg Oncol; 2010 Jul; 17(7):1777-86. PubMed ID: 20151217
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.
    Shoda K; Ichikawa D; Fujita Y; Masuda K; Hiramoto H; Hamada J; Arita T; Konishi H; Komatsu S; Shiozaki A; Kakihara N; Okamoto K; Taniguchi H; Imoto I; Otsuji E
    Gastric Cancer; 2017 Jan; 20(1):126-135. PubMed ID: 26874951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Takami H; Niwa Y; Yamada S; Fujii T; Sugimoto H; Kodera Y
    Br J Surg; 2018 Sep; 105(10):1349-1358. PubMed ID: 29741294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy.
    Hara K; Aoyama T; Hayashi T; Nakazono M; Nagasawa S; Shimoda Y; Kumazu Y; Numata M; Yamada T; Tamagawa H; Shiozawa M; Morinaga S; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
    Int J Clin Oncol; 2020 Apr; 25(4):584-594. PubMed ID: 31865480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
    Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
    Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots.
    Cao L; Hu X; Zhang J; Huang G; Zhang Y
    J Transl Med; 2014 Sep; 12():267. PubMed ID: 25245466
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.
    Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.